Berberine reduces HIF-1α levels by 40% in colonic tissue of DSS-induced colitis mice by downregulating the TLR4/NF-κB/HIF-1α axis, concurrently decreasing TNF-α and IL-6 secretion and alleviating inflammatory infiltration (Li et al., 2024). Here, NFKB1 is linked to colitis.